Cytek Biosciences, Inc. (CTKB)
4.675
+0.06
(+1.19%)
USD |
NASDAQ |
Sep 09, 13:52
Cytek Biosciences 1 Year Total Returns (Daily) : 12.68% for Sept. 8, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| September 08, 2026 | 12.68% |
| September 04, 2026 | 18.09% |
| September 03, 2026 | 19.29% |
| September 02, 2026 | 16.67% |
| September 01, 2026 | 11.59% |
| August 31, 2026 | 15.46% |
| August 28, 2026 | 12.23% |
| August 27, 2026 | 12.96% |
| August 26, 2026 | 9.86% |
| August 25, 2026 | 11.44% |
| August 24, 2026 | 6.99% |
| August 21, 2026 | 19.95% |
| August 20, 2026 | 16.50% |
| August 19, 2026 | 16.34% |
| August 18, 2026 | 15.02% |
| August 17, 2026 | 18.20% |
| August 14, 2026 | 14.95% |
| August 13, 2026 | 17.27% |
| August 12, 2026 | 18.61% |
| August 11, 2026 | 25.07% |
| August 10, 2026 | 15.63% |
| August 07, 2026 | 2.19% |
| August 06, 2026 | 6.94% |
| August 05, 2026 | 7.73% |
| August 04, 2026 | 11.46% |
| Date | Value |
|---|---|
| August 03, 2026 | 18.41% |
| July 31, 2026 | 17.22% |
| July 30, 2026 | 21.41% |
| July 29, 2026 | 21.67% |
| July 28, 2026 | 18.93% |
| July 27, 2026 | 19.51% |
| July 24, 2026 | 33.93% |
| July 23, 2026 | 35.31% |
| July 22, 2026 | 39.69% |
| July 21, 2026 | 47.42% |
| July 20, 2026 | 46.33% |
| July 17, 2026 | 40.00% |
| July 16, 2026 | 43.21% |
| July 15, 2026 | 43.08% |
| July 14, 2026 | 37.91% |
| July 13, 2026 | 30.72% |
| July 10, 2026 | 29.78% |
| July 09, 2026 | 28.21% |
| July 08, 2026 | 27.99% |
| July 07, 2026 | 34.12% |
| July 06, 2026 | 22.87% |
| July 02, 2026 | 27.15% |
| July 01, 2026 | 31.61% |
| June 30, 2026 | 30.29% |
| June 29, 2026 | 22.25% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Agilent Technologies, Inc. | 15.51% |
| Bio-Rad Laboratories, Inc. | 30.90% |
| Bruker Corp. | 90.44% |
| Danaher Corp. | 4.09% |
| Harvard Bioscience, Inc. | 74.88% |